Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting
Conclusion: Cilostazol seems to decrease total ISR rates in patients undergoing CAS without affecting MI/stroke/death events, both in the early and late settings.
Source: Journal of Endovascular Therapy - Category: Surgery Authors: Galyfos, G., Geropapas, G., Sigala, F., Aggeli, K., Sianou, A., Filis, K. Tags: Carotid Artery Stenting Source Type: research